• Ziarco Pharma header page image one
  • Ziarco Pharma header page image two
  • Ziarco Pharma header page image three

News & Events


Article posted: Dec 16, 2016

  Acquisition to add a once-daily oral H 4 receptor antagonist, ZPL389, to treat  atopic dermatitis, commonly known as...

Article posted: Aug 15, 2016

Abingdon, UK,  OBN Ltd, the membership organisation supporting the UK’s innovative life sciences companies, today announces the finalists of its...

Article posted: Jun 13, 2016

  - Clinically and statistically significant reduction in signs and symptoms of moderate to severe atopic dermatitis …

Article posted: May 16, 2016

  -       50% (p=0.01) improvement on EASI score at week 8 -       Full data to be presented...

Article posted: Jul 13, 2015

CANTERBURY, UK, 13 JULY, 2015   -- Ziarco Group Ltd., a clinical-stage biopharmaceutical company focusing on inflammatory diseases, today announced...


Article posted: Apr 26, 2016

EAACI Vienna, Austria http://www.eaaci.org/